Transrepression activity of T-box1 in a gene regulation network in mouse cells

Gene

Volumn 510, Issue 2, 2012, Pages 162-170

  Yee, Karen K L ^a   Yagi, Hisato ^a   Matsuoka, Rumiko ^a   Nakanishi, Toshio ^a   Furukawa, Toru ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

14 3 3 epsilon; Complement component 1 q subcomponent binding protein; DiGeorge syndrome; Gene expression; TBE; Tyrosine 3 monooxygenase tryptophan 5 monooxhygenase activated protein epsilon polypeptide

Indexed keywords

PROTEIN T BOX 1; T BOX TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; C1QBP GENE; GENE; GENE CONTROL; GENE MUTATION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; T BOX1 GENE; YWHAE GENE;

14-3-3 PROTEINS; ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; GENE DOSAGE; GENE KNOCKDOWN TECHNIQUES; GENE REGULATORY NETWORKS; HUMANS; MICE; MUTATION; RNA, SMALL INTERFERING; T-BOX DOMAIN PROTEINS;

EID: 84867329342     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.017     Document Type: Article

References (41)

1. Bi W., et al. Increased LIS1 expression affects human and mouse brain development. Nat. Genet. 2009, 41:168-177.
2. Bruno D.L., et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J. Med. Genet. 2010, 47:299-311.
3. Carreira S., Dexter T.J., Yavuzer U., Easty D.J., Goding C.R. Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol. Cell. Biol. 1998, 18:5099-5108.
4. Caterino M., et al. Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis. J. Proteome Res. 2009, 8:1515-1526.
5. Dobyns W.B., Curry C.J., Hoyme H.E., Turlington L., Ledbetter D.H. Clinical and molecular diagnosis of Miller-Dieker syndrome. Am. J. Hum. Genet. 1991, 48:584-594.
6. Farin H.F., Bussen M., Schmidt M.K., Singh M.K., Schuster-Gossler K., Kispert A. Transcriptional repression by the T-box proteins Tbx18 and Tbx15 depends on Groucho corepressors. J. Biol. Chem. 2007, 282:25748-25759.
7. Freyer L., Morrow B.E. Canonical Wnt signaling modulates Tbx1, Eya1, and Six1 expression, restricting neurogenesis in the otic vesicle. Dev. Dyn. 2010, 239:1708-1722.
8. Fulcoli F.G., Huynh T., Scambler P.J., Baldini A. Tbx1 regulates the BMP-Smad1 pathway in a transcription independent manner. PLoS One 2009, 4:e6049.
9. Ghosh T.K., Packham E.A., Bonser A.J., Robinson T.E., Cross S.J., Brook J.D. Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. Hum. Mol. Genet. 2001, 10:1983-1994.
10. Gong W., et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J. Med. Genet. 2001, 38:E45.
11. Goodship J., Cross I., Scambler P., Burn J. Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J. Med. Genet. 1995, 32:746-748.
12. Griffin H.R., et al. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 2010, 96:1651-1655.
13. Hu T., Yamagishi H., Maeda J., McAnally J., Yamagishi C., Srivastava D. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 2004, 131:5491-5502.
14. Huang L., Chi J., Berry F.B., Footz T.K., Sharp M.W., Walter M.A. Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells. Invest. Ophthalmol. Vis. Sci. 2008, 49:5243-5249.
15. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 2001, 27:286-291.
16. Kispert A., Hermann B.G. The Brachyury gene encodes a novel DNA binding protein. EMBO J. 1993, 12:4898-4899.
17. Kispert A., Koschorz B., Herrmann B.G. The T protein encoded by Brachyury is a tissue-specific transcription factor. EMBO J. 1995, 14:4763-4772.
18. Liao J., et al. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum. Mol. Genet. 2004, 13:1577-1585.
19. Lingbeek M.E., Jacobs J.J., van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem. 2002, 277:26120-26127.
20. Maeda J., Yamagishi H., McAnally J., Yamagishi C., Srivastava D. Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev. Dyn. 2006, 235:701-710.
21. Matsuoka R., et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum. Genet. 1998, 103:70-80.
22. Nagamani S.C., et al. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J. Med. Genet. 2009, 46:825-833.
23. Okubo T., et al. Ripply3, a Tbx1 repressor, is required for development of the pharyngeal apparatus and its derivatives in mice. Development 2011, 138:339-348.
24. Paylor R., et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7729-7734.
25. Radosevic M., Robert-Moreno A., Coolen M., Bally-Cuif L., Alsina B. Her9 represses neurogenic fate downstream of Tbx1 and retinoic acid signaling in the inner ear. Development 2011, 138:397-408.
26. Raft S., Nowotschin S., Liao J., Morrow B.E. Suppression of neural fate and control of inner ear morphogenesis by Tbx1. Development 2004, 131:1801-1812.
27. Roos L., et al. A new microduplication syndrome encompassing the region of the Miller-Dieker (17p13 deletion) syndrome. J. Med. Genet. 2009, 46:703-710.
28. Shprintzen R.J. Velo-cardio-facial syndrome. Management of Genetic Syndromes 2005, 615-631. Wiley, Hoboken. S.B. Cassidy, J.E. Allanson (Eds.).
29. Sinha S., Abraham S., Gronostajski R.M., Campbell C.E. Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2. Gene 2000, 258:15-29.
30. Sousa-Nunes R., et al. Characterizing embryonic gene expression patterns in the mouse using nonredundant sequence-based selection. Genome Res. 2003, 13:2609-2620.
31. Stoller J.Z., et al. Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp. Biol. Med. (Maywood) 2010, 235:569-576.
32. Takao A., Masashiko A., Cho K., Kinouchi A., Murakami Y. Etiologic categorization of common congenital heart disease. Etiology and Morphogenesis of Congenital Heart Disease 1980, 540. Futura Pub. Co. R.V. Praagh, A. Takao (Eds.).
33. Tazumi S., Yabe S., Uchiyama H. Paraxial T-box genes, Tbx6 and Tbx1, are required for cranial chondrogenesis and myogenesis. Dev. Biol. 2010, 346:170-180.
34. van Bueren K.L., et al. Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Dev. Biol. 2010, 340:369-380.
35. van der Heyden M.A., Defize L.H. Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc. Res. 2003, 58:292-302.
36. Wilson V., Conlon F.L. The T-box family. Genome Biol. 2002, 3. (REVIEWS3008).
37. Xu H., Viola A., Zhang Z., Gerken C.P., Lindsay-Illingworth E.A., Baldini A. Tbx1 regulates population, proliferation and cell fate determination of otic epithelial cells. Dev. Biol. 2007, 302:670-682.
38. Yagi H., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362:1366-1373.
39. Zhang Z., Baldini A. In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum. Mol. Genet. 2008, 17:150-157.
40. Zheng Y.H., Yu H.F., Peterlin B.M. Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat. Cell Biol. 2003, 5:611-618.
41. Zweier C., Sticht H., Aydin-Yaylagul I., Campbell C.E., Rauch A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am. J. Hum. Genet. 2007, 80:510-517.